kcgi cmo

Samsung Biologics Co., the world’s largest contract manufacturing organization (CMO), said on Monday it has secured a $5.14 million order from...

South Korea's Samsung Biologics Co., the world’s largest contract drugmaker, said on Tuesday it signed a $1.4 billion contract manufacturing o...

KCGI, a South Korean private equity firm, has agreed to buy a controlling stake in Hanyang Securities Co. for 220.3 billion won ($166 million), slig...

KCGI, a South Korean private equity firm, has been struggling to raise funds for its 244.9-billion-won ($183 million) purchase of a controlling stak...

South Korean private equity firm KCGI Co. is expected to acquire local brokerage house Hanyang Securities Co. for 244.9 billion won ($179.8 million)...

Hanyang Securities Co. has received preliminary bids from four to five South Korean companies or consortia for its 11.3% stake after its controlling...

Hanyang Securities Co., a small South Korean brokerage firm, has been put on the market as its parent Hanyang University Foundation scrambles to kee...

Samsung Group is on track to rise to the top of biosimilar companies in the world and become South Korea’s largest drug maker for contract man...

Samsung Biologics Co., the world’s top contract manufacturing organization (CMO) by capacity, surpassed the annual contract manufacturing orde...

Hyundai Group's chairwoman on Friday resigned from the board of its elevator unit, whose No. 2 shareholder is Schindler Holding AG, amid mounting sh...

South Korea’s KCGI Asset Management, formerly Meritz Asset Management, announced on Friday that it has hired Cho Won-bok, former division head...

SK Bioscience Co., the drug-making unit of South Korea’s SK Group, said on Wednesday it has signed a deal to buy 6.5 million shares in US vacc...

A sibling feud over management control of DB Group is expected to intensify following the ascent of South Korean activist fund Korea Corporate Gover...

Korea Corporate Governance Improvement Fund (KCGI) is eyeing a controlling stake in DB HiTek Co. as the activist fund became the second-largest shar...

South Korean leading foundry chipmaker DB HiTek’s stock price hit a near 10-month high this week as a domestic activist fund bought a stake to...

Samsung Biologics Co., the world’s No. 1 contract drug maker in terms of production capacity, has won a $182.7 million contract manufacturing ...

Celltrion Pharm Inc., a South Korean biopharmaceutical company, said on Monday it received certification from Brazil’s health regulator for it...

Korea Corporate Governance Improvement Fund (KCGI), one of the country’s most aggressive shareholder activists, plans to sell its stake in Oss...

South Korean private equity firm Unison Capital Korea is set to focus on boosting the corporate value of Osstem Implant Co., once the PE manager and...

A consortium led by Korea Corporate Governance Improvement Fund (KCGI), a local activist fund, said on Jan. 9 it signed a share purchase agreement l...

South Korea’s Meritz Financial Group Inc. is poised to sell off its subsidiary Meritz Asset Management Co., The Korea Economic Daily understoo...

South Korea’s Samsung Biologics Co. has signed a $296.1 million deal to supply biopharmaceutical products to UK-based multinational pharma gia...

South Korea’s Samsung Biologics Co. has inked an $81 million contract manufacturing deal with Novartis, the world’s fifth-largest pharma...

Activist fund Korea Corporate Governance Improvement Fund (KCGI) recently exited its investment in Hanjin KAL Co., the parent company of Korean Air ...

SK Inc., the investment and holding company of South Korea’s SK Group, is seeking to make COVID-19 treatment pills developed by Pfizer Inc. an...

South Korea’s microbiome medicine developer Genome & Company geared up for entering the U.S. market to boost profits and make inroads into...

A South Korean electric bus maker Edison Motors Co. added the activist fund Korea Corporate Government Improvement Fund (KCGI) as a financial invest...

German biopharmaceutical company CureVac N.V. may choose South Korea as one of its global production bases for the COVID-19 vaccine following Korean...

SK Inc., the holding and investment company of SK Group, South Korea’s third-largest conglomerate, has acquired a 70% stake in Yposkesi, a Fre...

South Korea is emerging as a global hub for the contract manufacturing of biopharmaceuticals following its latest deal to procure COVID-19 vaccines ...